首页> 外文期刊>Stem cells translational medicine. >Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury
【24h】

Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury

机译:简洁评论:弥合差距:脊髓损伤中的新型神经再生和神经保护策略

获取原文
           

摘要

Spinal cord injuries (SCIs) result in devastating lifelong disability for patients and their families. The initial mechanical trauma is followed by a damaging secondary injury cascade involving proapoptotic signaling, ischemia, and inflammatory cell infiltration. Ongoing cellular necrosis releases ATP, DNA, glutamate, and free radicals to create a cytotoxic postinjury milieu. Long-term regeneration of lost or injured networks is further impeded by cystic cavitation and the formation of an inhibitory glial-chondroitin sulfate proteoglycan scar. In this article, we discuss important neuroprotective interventions currently applied in clinical practice, including surgical decompression, blood pressure augmentation, and i.v. methylprednisolone. We then explore exciting translational therapies on the horizon, such as riluzole, minocycline, fibroblast growth factor, magnesium, and hypothermia. Finally, we summarize the key neuroregenerative strategies of the next decade, including glial scar degradation, Rho-ROCK inhibition, cell-based therapies, and novel bioengineered adjuncts. Throughout, we emphasize the need for combinatorial approaches to this multifactorial problem and discuss relevant studies at the forefront of translation. We conclude by providing our perspectives on the future direction of SCI research.Spinal cord injuries (SCIs) result in devastating, lifelong disability for patients and their families. This article discusses important neuroprotective interventions currently applied in clinical practice, including surgical decompression, blood pressure augmentation, and i.v. methylprednisolone. Translational therapies on the horizon are discussed, such as riluzole, minocycline, fibroblast growth factor, magnesium, and hypothermia. The key neuroregenerative strategies of the next decade are summarized, including glial scar degradation, Rho-ROCK inhibition, cell-based therapies, and novel bioengineered adjuncts. The need for combinatorial approaches to this multifactorial problem is emphasized, relevant studies at the forefront of translation are discussed, and perspectives on the future direction of SCI research are presented.
机译:脊髓损伤(SCI)会给患者及其家人带来毁灭性的终生残疾。最初的机械创伤后是继发性破坏性继发性损伤,包括促凋亡信号传导,局部缺血和炎性细胞浸润。持续的细胞坏死释放出ATP,DNA,谷氨酸和自由基,从而产生细胞毒性的损伤后环境。囊性空化和抑制性胶质硫酸软骨素硫酸盐蛋白聚糖疤痕的形成进一步阻碍了丢失或受损网络的长期再生。在本文中,我们讨论了目前在临床实践中应用的重要神经保护性干预措施,包括手术减压,血压升高和静脉输液。甲基泼尼松龙。然后,我们在地平线上探索令人兴奋的翻译疗法,例如利鲁唑,米诺环素,成纤维细胞生长因子,镁和体温过低。最后,我们总结了下一个十年的关键神经再生策略,包括神经胶质疤痕退化,Rho-ROCK抑制,基于细胞的疗法以及新型生物工程辅助剂。在整个过程中,我们强调需要采用组合方法来解决这一多因素问题,并在翻译的最前沿讨论相关研究。最后,我们对SCI研究的未来方向提出了自己的看法。脊髓损伤(SCI)会给患者及其家庭带来毁灭性的终身残疾。本文讨论了目前在临床实践中应用的重要神经保护性干预措施,包括手术减压,血压升高和静脉输液。甲基泼尼松龙。讨论了即将出现的转化疗法,例如利鲁唑,米诺环素,成纤维细胞生长因子,镁和体温过低。总结了下一个十年的关键神经再生策略,包括神经胶质疤痕退化,Rho-ROCK抑制,基于细胞的疗法以及新型生物工程辅助剂。强调了针对此多因素问题的组合方法的需求,讨论了翻译前沿的相关研究,并提出了对SCI研究的未来方向的看法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号